Obalon Announces Fourth Quarter and Full Year 2018 Financial Results
February 22, 2019 08:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Fourth Quarter and Year End 2018 Financial Results Conference Call for February 22, 2019 at 8:30 a.m. Eastern Time
February 15, 2019 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Second Quarter 2018 Financial Results Conference Call for August 2, 2018 at 8:30 a.m. Eastern Time
July 24, 2018 10:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 24, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Full Year 2017
January 05, 2018 08:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) today reported that it achieved preliminary, unaudited revenue of approximately $3.9 million for the fourth...
Obalon Schedules Fourth Quarter and Full Year 2017 Preliminary, Unaudited Revenue and Business Update Conference Call for January 5, 2018 at 8:30 a.m. Eastern Time
January 04, 2018 17:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Third Quarter 2017 Financial Results Conference Call for November 3, 2017 at 8:30 a.m. Eastern Time
October 26, 2017 08:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...